FDA Grants Accelerated Approval For Sarepta Muscular Dystrophy Drug Eteplirsen The FDA has approved the first drug to treat Duchenne muscular dystrophy. The agency's decision went against the recommendation of the panel of experts who did not find eteplirsen effective. by Rhodi Lee
Health FDA Panel Gives Thumbs Down To Sarepta Duchenne Muscular Dystrophy Drug Eteplirsen by Angela Laguipo
Healthy Living/Wellness Sarepta again seeks FDA approval for drug treating Duchenne muscular dystrophy by Anu Passary